SOURCE: Model N, Inc.

Model N, Inc.

April 29, 2009 03:01 ET

Leading Generic Pharmaceutical Manufacturer Selects Full Suite of Model N Commercial and Regulatory Revenue Management Applications

Deployment Will Replace Legacy I-many System With Model N's Proven Solutions to Enhance Regulatory Compliance and Commercial and Government Contracting

REDWOOD SHORES, CA--(Marketwire - April 29, 2009) - Model N, the leader in Revenue Management, today announced that a leading manufacturer of generic and branded pharmaceutical products has selected and begun implementation of the full Model N Pharmaceutical Revenue Management Suite to complement its newly upgraded ERP system with comprehensive regulatory compliance, commercial and government contracting, and analytics capabilities. The company is upgrading its legacy I-many system with Model N's fully integrated, end-to-end solution that aligns pricing, contracting, regulatory compliance, and settlements processes across both commercial and government businesses. The selection came after a careful evaluation of competitive offerings, including the incumbent vendor's proposed next-generation solution.

Model N Revenue Management Benefits

Last year, Model N released version 5.3 of its Revenue Management Suite, which supports critical generics business activities, from frequent contract and pricing updates to complex and varied discounts and incentive deal structures. Highlights of the release relevant to this deployment include:

--  Robust reporting and analytics that provide insights into key business
--  Rebating and contracting flexibility that improves business
--  Proven integration through SAP adapters that realizes maximum returns
    from SAP investments
--  Advanced government pricing policy management that reduces regulatory
--  Integrated regulatory and commercial applications that increase
    visibility to the implications of pricing and contracting decisions that
    cross commercial and government contracts
--  Purpose-built functionality that supports high-volume, generics-
    specific business processes

Supporting Quote

"Adding another important generics customer to our roster highlights the commitment we've made to the generics side of the industry and further validates the importance of Revenue Management as a strategic business process for all pharmaceutical manufacturers regardless of their line of business," said Sujay Jadhav, Life Sciences General Manager at Model N. "This win also reflects our ability to provide customers with a seamless migration path from legacy vendor systems to a proven suite of applications that have become the new standard in Life Sciences Revenue Management."

Supporting Resources

AMR Research Report: How to Grow Revenue and Margins in a Downturn

Model N Revenue Management for Generics

Web Seminar with IMS: Overcoming Contracting and Pricing Challenges in the Generics Industry

AMR Research Report: Using Revenue and Contract Management as a Strategic Weapon

About Model N

Model N is the leader in Revenue Management solutions, offering an integrated suite of applications for pricing, contracts, compliance, rebates, fees, chargebacks, and analytics optimized for the industry practices of life sciences companies, with the only integrated government pricing and Medicaid claims processing capabilities in the industry.

Model N is a registered trademark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

Contact Information

  • Contact

    Sean Cassidy
    Model N, Inc.
    Tel: 650-610-4820
    Email Contact